Skip to main content
. Author manuscript; available in PMC: 2024 May 3.
Published in final edited form as: Int J Cancer. 2020 Aug 31;148(1):77–89. doi: 10.1002/ijc.33196

Table 3.

HRs (95% CIs) for colorectal cancer by quartiles of dietary intake of n-6 and n-3 PUFA (N=59,986)

Q1 Q2 Q3 Q4 p trend

Total n-6PUFA
 No. of cases/person-years 186/177,229 217/176,460 231/177,444 242/179,661
 Age, energy intake adjusted HR a 1 (ref.) 1.11 (0.91–1.35) 1.14 (0.94–1.38) 1.14 (0.94–1.38) 0.21
 Multivariable HR b 1 (ref.) 1.16 (0.95–1.41) 1.20 (0.98–1.47) 1.18 (0.95–1.47) 0.16
Linoleic acid (LA) 18:2
 No. of cases/person-years 184/177,212 218/176,437 232/177,460 242/179,684
 Age, energy intake adjusted HR a 1 (ref.) 1.13 (0.93–1.37) 1.15 (0.95–1.40) 1.15 (0.95–1.39) 0.19
 Multivariable HR b 1 (ref.) 1.18 (0.96–1.44) 1.22 (0.99–1.49) 1.19 (0.96–1.48) 0.15
Arachidonic acid (AA) 20:4
 No. of cases/person-years 246/175,841 212/176,601 212/178,158 206/180,195
 Age, energy intake adjusted HR a 1 (ref.) 0.87 (0.72–1.05) 0.87 (0.73–1.05) 0.91 (0.76–1.10) 0.38
 Multivariable HR b 1 (ref.) 0.89 (0.74–1.07) 0.89 (0.74–1.08) 0.89 (0.73–1.09) 0.30

Total n-3PUFA
 No. of cases/person-years 210/175,390 219/176,252 233/178,258 214/180,894
 Age, energy intake adjusted HR a 1 (ref.) 1.03 (0.85–1.25) 1.11 (0.92–1.34) 1.07 (0.88–1.29) 0.39
 Multivariable HR b 1 (ref.) 1.08 (0.89–1.31) 1.16 (0.95–1.42) 1.09 (0.87–1.36) 0.42
n-3HUFA
 No. of cases/person-years 249/175,078 253/176,174 194/178,154 180/181,388
 Age, energy intake adjusted HR a 1 (ref.) 1.07 (0.90–1.27) 0.93 (0.77–1.21) 0.96 (0.79–1.17) 0.44
 Multivariable HRb 1 (ref.) 1.08 (0.91–1.29) 0.94 (0.78–1.14) 0.94 (0.77–1.15) 0.35
Marine-derived PUFA
 No. of cases/person-years 254/175,133 248/176,164 195/178,243 179/181,254
 Age, energy intake adjusted HR a 1 (ref.) 1.03 (0.86–1.22) 0.92 (0.76–1.11) 0.94 (0.77–1.14) 0.36
 Multivariable HR b 1 (ref.) 1.04 (0.87–1.24) 0.93 (0.77–1.12) 0.92 (0.75–1.12) 0.27
Alpha linolenic acid (ALA) C18:3
 No. of cases/person-years 199/175,846 212/176,614 240/177,848 225/180,487
 Age, energy intake adjusted HR a 1 (ref.) 1.04 (0.86–1.26) 1.17 (0.97–1.42) 1.10 (0.91–1.33) 0.22
 Multivariable HR b 1 (ref.) 1.09 (0.89–1.33) 1.25 (1.02–1.52) 1.15 (0.92–1.43) 0.18
Eicosapentaenoic acid (EPA) C20:5
 No. of cases/person-years 250/175,036 248/176,047 201/178,266 177/181,445
 Age, energy intake adjusted HR a 1 (ref.) 1.04 (0.87–1.23) 0.95 (0.79–1.15) 0.95 (0.78–1.15) 0.47
 Multivariable HR b 1 (ref.) 1.05 (0.88–1.25) 0.96 (0.79–1.16) 0.93 (0.75–1.14) 0.33
Docosapentaenoic acid (DPA) C22:5
No. of cases/person-years 241/174,933 252/176,140 201/178,019 182/181,702
Age, energy intake adjusted HR a 1 (ref.) 1.10 (0.92–1.31) 0.98 (0.81–1.18) 1.00 (0.82–1.21) 0.69
Multivariable HR b 1 (ref.) 1.12 (0.93–1.33) 1.00 (0.82–1.21) 0.99 (0.81–1.21) 0.63
Docosahexanoic acid (DHA) C22:6
 No. of cases/person-years 254/175,152 243/176,161 198/178,225 181/181,256
 Age, energy intake adjusted HR a 1 (ref.) 1.01 (0.85–1.20) 0.93 (0.77–1.12) 0.94 (0.78–1.14) 0.43
 Multivariable HR b 1 (ref.) 1.02 (0.86–1.22) 0.95 (0.78–1.14) 0.92 (0.76–1.13) 0.34

Ratio n-6PUFA/n-3 PUFA
 No. of cases/person-years 183/180,326 194/179,208 225/177,344 274/173,915
 Age, energy intake adjusted HR a 1 (ref.) 0.94 (0.77–1.15) 0.99 (0.81–1.20) 1.08 (0.89–1.30) 0.29
 Multivariable HR b 1 (ref.) 0.96 (0.78–1.18) 1.02 (0.83–1.24) 1.11 (0.91–1.36) 0.22
a

Model 1: Cox proportional hazards model was adjusted for age, and total energy intake (residual method).

b

Model 2: Cox proportional hazards model was adjusted for age, total energy intake (residual method), education levels, alcohol consumption (continuous - drinks/day), family history of CRC, history of other diseases (cancer, myocardial infarction, stroke or diabetes mellitus), BMI (continuous - kg/m2), physical activity (continuous - MET-hour/week), fiber intake, calcium intake (kcal/day, continous) and was stratified income levels and cigarette smoking.

Total n-6 PUFA: LA + AA; Total n-3 PUFA: EPA + DHA + ALA + DPA or EPA + DHA + ALA; n-3 HUFA: EPA + DHA + DPA; Marine-derived PUFA: EPA + DHA.